Your trusted source for investing success

Tag: research

5 Top Biotech Stocks on the TSX Year-to-date

5 Top Biotech Stocks on the TSX Year-to-date

The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.

Q BioMed Announces Development Partnership With Sphaera Pharma

Q BioMed Announces Development Partnership With Sphaera Pharma

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company, announced today a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder.

 “The goal of our collaboration with Sphaera Pharma is to put the patient first, especially since QBM-001 targets a rare subset of toddlers

Hydropothecary Announces Kosher Certification on Processed Medical Marijuana Products

Hydropothecary Announces Kosher Certification on Processed Medical Marijuana Products

The Hydropothecary Corporation (“THCX” or the “Company”) (TSXV:THCX) is pleased to announce its processed medical marijuana products have been granted kosher certification by the Ottawa Vaad HaKashrut. It is the only kosher certification currently granted to cannabis products in Canada.

The kosher certification, includes Decarb, the ready-to-consume activated marijuana powder product

AnalytixInsight and Africa Investor Launch Financial Portal for African Market

AnalytixInsight (TSXV:ALY) has announced the launch of online portal www.aianalytix.com for comprehensive company analysis, including on-demand fundamental research, portfolio evaluation and screening tools for publicly listed companies in Africa.

As quoted in the press release:
As previously reported on August 28, 2017, AnalytixInsight has entered into a content agreement with Ai to

Chinese Partners’ Testwork Elevates Chilalo Into a Class of its Own

Graphex Mining (ASX: GPX) is pleased to announce the exceptional testwork results achieved by the Suzhou Design and Research Institute for Non-Metallic Minerals (‘Suzhou’) on behalf of CN Docking Joint Investment and Development (‘CN Docking’), a subsidiary of China National Building Materials, as part of their technical due diligence undertaken

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the U.S. Food and Drug Administration (“FDA”) has allowed an additional Investigational New Drug Application (“IND”) to study its lead drug candidate VAL-083 as a potential treatment for ovarian cancer.

 “The opening of this

Tech Forecast and Promising Tech Stocks To Buy in 2017

Learn about breakthrough technology about to impact lives around the globe. We cover the entire industry in our FREE investor’s report.   Gain Access
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
What are Class 3 Medical Devices?

URL: https://investingnews.com/daily/life-science-investing/medical-device-investing/class-3-medical-devices/